Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 5Terminated 3Recruiting 3Unknown 2Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Thyroid Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Liver Cirrhosis 1HER2-positive Breast Cancer 1Glioma 1Glioblastoma 1Cytoreductive Surgery 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Cisplatin 9pembrolizumab 7Radiosurgery 6Gemcitabine 6Paclitaxel 5Dexamethasone 5Taxes 4Carboplatin 4trametinib 3ibrutinib 3Surveys and Questionnaires 3Standard of Care 3Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3Lenalidomide 3Fluorouracil 3Erlotinib Hydrochloride 3Blood Specimen Collection 3Ascorbic Acid 3venetoclax 2veliparib 2tocilizumab 2pazopanib 2obinutuzumab 2naquotinib 2lenvatinib 2fludarabine 2enzalutamide 2Vemurafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms × Fluorodeoxyglucose F18 × Clear all
NCT03107325 2020-10-06

Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging

Boston Children's Hospital

Phase 4 Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡